Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of furosemide for prevention of volume overload in children with transfusion-dependent thalassemia
TCTR20180209001Phase 3Not yet recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of furosemide in Thalassaemia, sponsored by Phramongkutklao Hospital. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
furosemide
03
Conditions
Thalassaemia
Beyond the preview
Go deeper on TCTR20180209001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180209001.